Black Diamond Therapeutics Inc
Biotechnology
Healthcare
BDTX
56.51 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.22
52 week high
6.58
high
1.44
52 week low
1.36
low
1.20
growth
-71.78 %
previous Close
1.36
P/E ratio
market cap
124 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-15.56 M
21.86 %
eps
0.00 %
23.53 %
eps surprise
25.59 %
net profit margin
-1555700000.00 %
0.00 %
operating incoming
-18.13 M
18.08 %
net change in cash
-8.56 M
-215.85 %
cash on hand
23.43 M
-28.61 %
cost of revenue
86.00 K
0.00 %
top top